Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

Joining us is the company Sanofi and Regeneron to talk to us more about COPD also known as Chronic Obstructive Pulmonary ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

This approval was based on results from the phase 3 BOREAS (NCT03930732) and NOTUS (NCT04456673) trials, which demonstrated that dupilumab can significantly reduce COPD exacerbations. 2 The first ...

Opens in a new tab or window “Compared to non-CMR recipients, CMR recipients experienced a considerably higher increase in adherence to COPD medications from 2016 to 2017, and findings with data ...

Dupixent is an “add-on” drug for COPD, meaning patients take it in addition to inhaled medication Dupixent isn’t approved as a stand-alone treatment for COPD. The U.S. Food and Drug ...

Study objectives: To identify the predictors of medication adherence in patients with COPD and contrast the health beliefs, experiences, and behaviors of COPD patients self-reporting good ...

The medication adherence report scale (MARS ... A nutrition guide for patients with COPD was included as an ethically acceptable incentive to encourage patient response. The study received ...